- Pressemitteilung BoxID 153578
MEDA: Hitting allergy symptoms right where it hurts! Applying antihistamines directly to the source of the problem improves quality of life for hay fever sufferers!
Direct application at the site - the key to success
Numerous professional associations, such as the World Health Organization (WHO), agree that antihistamines, applied either topically in the form of a nasal spray or given orally in tablet form, are the remedy of choice for allergic rhinitis. You may think that it doesn't matter how you take the medication, just as long as you take it? Well, you'll be surprised to learn that the method of application plays a decisive role in how effective the medication is. A recently published scientific study by Professor Friedrich Horak of the University of Vienna confirmed that the anti-histamine Azelastine was more effective as a locally-applied nasal spray than other anti-histamines given as tablets (Horak und Zieglmayer 2009). Because Azelastine is applied directly at the site of all those annoying symptoms (i.e. on either the mucous membranes inside the nose or in the eyes), it gets to work much faster than allergy medications that must be taken as tablets. This is because tablets need to be broken down in the stomach and absorbed into the blood before being transported to the site of the allergic reaction (quite a journey!). This greatly slows down their effectiveness. Indeed, Professor Horak also found that Azelastine nasal spray was effective even in those patients who had failed to respond to antihistamine tablets. Another problem with medications given in tablet form is that they can interact with other oral medications taken at the same time. The use of a nasal spray reduces this undesired risk of interactions with accompanying medications, making Azelastine a very well-tolerated anti-histamine.
Many good reasons for choosing Azelastine
Millions of people all over the world suffer from the troublesome symptoms of rhinitis - and the numbers continue to grow! An alarming 66% of all sufferers are not satisfied with their current allergy treatment because they are not getting the desired results (Anon 2006). An effective, flexible, and safe method of treatment that is compatible with patients' individual needs is the only way to save allergy sufferers both from their tiring symptoms, and from the frustration that comes from inadequate treatment. Azelastine makes customized treatment possible. This modern antihistamine shows fast results within 15 minutes, allowing sufferers to actually wait until their symptoms appear before using the anti-allergy treatment. Allergy sufferers no longer need to have a degree in meteorology, keeping abreast of pollen count forecasts and taking their medication in advance! Allergy medications with other active ingredients such as glucocorticoids, which are very effective in inhibiting infections, or cromoglycates, which stabilize the cells that release histamines, must be taken several days before possible pollen exposure, and must be continued throughout the entire duration of pollen season. In comparison to other medications, Azelastine offers allergy sufferers a true advantage. Hay fever sufferers are free to choose their activities regardless of the pollen count! Because Azelastine works quickly and remains effective for up to 12 hours, it is only necessary to use the spray in the morning and the evening. This individualized and uncomplicated medication lets allergy sufferers enjoy the coming of spring again. Bring it on!
Horak F, Zieglmayer UP 2009, Clin Immunol 5(6): 659-69 Anon 2006, Survey of nasal allergy sufferers, HealthSTAR Communications
For more information, visit:
Über MEDA Pharma GmbH & Co. KG
MEDA AB (publ) is a leading international specialty pharmaceutical company. Meda is represented by locations in over 40 countries and its products are sold in 120 countries worldwide. Meda shares are listed under Large Cap on the Nasdaq OMX Nordic Stock Exchange in Stockholm. For more information, visit www.meda.se.
Diese Pressemitteilungen könnten Sie auch interessieren
Fehlende Mittel für Prothesen und Orthesen und keine Aussicht auf Hilfe – für uns Deutsche mit einer funktionierenden Gesundheitsversorgung...
Ausländische Versandapotheken müssen sich nicht länger an die deutsche Arzneimittelpreisverordnung (AMPreisV) halten. Das hat der Europäische...